Aldabra Capital
Via del Gesù, 62, Rome, Lazio, 00186, Italy
Overview
Aldabra Capital is an investment holding company that specializes in venture capital, private equity, and financial advisory operations. It supports the growth of innovative small and medium-sized companies, which offers experience and expertise together with an influential network of solid national and international relations. The firm's investment philosophy is always carried out together with entrepreneurs, both in the case of direct participation in the capital, and in the evaluation phase, Aldabra plays the role of advisor. Aldabra offers the possibility of making available to entrepreneurs and co-investors, in addition to financial support, a wide range of strategic and technical skills from direct operational management, to planning and control, to legal and administrative aspects, to financial management.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Aggrade
Participated · Equity · Oct 2016
Aggrade develops an innovative aerodynamic granulation technology to formulate pharmaceutical drugs and nutraceutical products, aiming to improve oral drug bioavailability and simplify formulation processes. The company targets extending marketed drug platforms to include agents entirely insoluble in water. Co‑founded by Giovanni Politi and Vincenzo Politi in 2013, Aggrade operates from Camberley, United Kingdom. It recently signed a deal with nutraceutic company BioDue under which BioDue will build an industrial facility to produce dietary supplements using Aggrade’s system in exchange for royalties. Aggrade intends to use new funding to conduct R&D activities and expand the business.
- Crest Optics
Participated · Equity · Jun 2013
Crest Optics is a Rome, Italy–based bioscience startup that uses optical and electro‑optical technology to develop instruments for scientific and industrial applications. Its core products include X-light and complementary systems targeting fluorescence microscopy and spectroscopy. The company is a subsidiary of Crisel Instruments and was founded and is led by President Vincenzo Ricco. It raised €400k in equity funding from Filas and Aldabra Capital, with Aldabra acquiring a 35% stake. Crest Optics intends to use the funds to accelerate the commercialization of X-light and to develop further systems through the Istituto Italiano di Tecnologia. The funding announcement was reported on 16 June 2013.
Team
No current team members are available.